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Minimal Information About Sample Preparation for Phosphoproteomics 
Version 0.91, April 2009 
Montserrat Carrascal, David Ovelleiro, Marina Gay and Joaquin Abian.  
LP-CSIC/UAB, IIBB-CSIC, IDIBAPS, Rosellón 161, 7 Planta, 08036 Barcelona, Spain.  
  
This module identifies the minimum information required to report sample preparation 
conditions in a phosphoproteomics experiment according to the MIAPE Principles.   
   
Introduction 
In the study of the phosphoproteome, sample preparation for peptide or protein enrichment is an 
especially critical step. In most cases, this is achieved using a combination of procedures including 
HPLC separation of peptides or proteins, gel electrophoresis and enrichment methods such as 
immunoaffinity or IMAC and TiO2-based purification procedures.  
  
This guideline describes parameters and conditions involved in phosphopeptide identification by mass 
spectrometry. It covers from the description and preparation of the cells and tissues to the 
fractionation and specific enrichment of phosphopeptides for MS analysis. The guideline is prepared 
in order to easily cope with many of the experimental designs used in phosphoproteomic studies.  
  
The document is subdivided as follows: 
1. General features 
2. Sample processing 
3. Protein Purification/Fractionation 
4. Peptide Purification/Fractionation 
5. Phosphopeptide enrichment 
  
If procedures are repeated more than once, the corresponding section should be repeated (e.g. More 
than one purification method for phosphopeptide enrichment). 
 
In sections where the methodology described has been already documented as part of other MIAPEs 
(1D SDS-PAGE and HPLC purifications), the corresponding sections have been imported from them. 
Thus, this proposal includes some definitions from HUPO-PSI Gel Electrophoresis vs. 1.4, January 
2008 and Column Chromatography vs. 1.0, June 2008 documents.  
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Reporting requirement for Sample Preparation for Phosphoproteomics 
  
1. General features   
1.1  Date stamp (as yyyy-mm-dd)  
1.2  Responsible person or institutional role  
1.3  Sample/s name/s 
1.4  Replicates  
 
 
2. Sample processing   
 
2.1  Culture/tissue handling   
   - Tissue/Cell/Fluid type  
   - Source  
   - Species  
   - Isolation/Collection Method  
2.1.1  Cells  
2.1.1.1  Cell Isolation Method  
2.1.1.2 Culture parameters  
   - Culture medium  
   - Culture conditions  
   - Cell density  
   - Type of culture  
   - Time of culture  
2.1.1.3 Cell treatment  
  - Starting amount  
  - Culture medium  
  - Culture conditions  
  - Cell Treatment  
  - Cell density  
  - Time  
2.1.1.4 Pellet preparation  
2.1.1.5 Cell/Pellet lysis  
  - Starting amount 
  - Lysis buffer  
  - Phosphatase inhibitors used  
  - Other enzyme inhibitors 
  - Volume  
  - Homogenization or sonication methods  
  - Centrifugation  
2.1.1.6 Other procedures  
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2.1.2 Solid Tissues  
2.1.2.1 Tissue disruption  
  - Starting amount 
  - Lysis buffer  
  - Phosphatase inhibitors used  
  - Other enzyme inhibitors 
  - Volume  
  - Homogenization or sonication methods  
  - Centrifugation  
2.1.2.2 Other procedures  
2.1.3 Fluids  
  - Starting volume  
  - Buffer used for dilution 
  - Phosphatase inhibitors used  
  - Other enzyme inhibitors 
  - Protein deplection method (if required) 
2.2 Protein Precipitation  
  - Starting volume  
  - Reagents and conditions  
  - Centrifugation  
  - Redisolution  
2.3 Protein Digestion  
  - Starting amount  
2.3.1 Pretreatment  
  - Reduction  
  - Alkykation  
  - Others  
2.3.2 Digestion parameters  
  - Protein concentration  
  - Digestion buffer  
  - Enzyme  
  - Incubation parameters 
2.4 Peptide/Protein Labeling  
  - Type of labeling  
  - Significative customizations  
2.5 Other treatments  
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3. Protein Purification/Fractionation   
 
3.1  1D SDS-PAGE and in-gel digestion  
  - Starting material 
3.1.1 Gel matrix and electrophoresis   
  - Description of gel matrix  
  - Gel manufacturer  
  - Physical dimensions  
  - Physicochemical property range and distribution  
  - Acrylamide concentration  
  - Acrylamide:crosslinker ratio  
  - Gel lane  
  - Sample application  
  - Buffer  
  - Equipment  
  - Electrophoresis conditions  
3.1.2 Staining  
3.1.3 In gel digestion  
  - Digestion buffer  
  - Enzyme  
  - Incubation parameters 
  - Previous treatment  
  - Automatic digestor  
3.2 HPLC and liquid digestion 
  - Starting material 
3.2.1 Equipment   
3.2.1.1 Product details for column   
  -Make  
  -Model  
  -Separation mode  
3.2.1.2 Physical characteristics of column  
  -Length  
  -Diameter  
  -Description of stationary phase  
3.2.1.3 Chromatography system used for separation, where applicable  
3.2.1.4 Mobile phase: for each mobile phase   
  -Name of mobile phase  
  - Description of the constituents  
3.2.1.5 Properties of the column run  
  -Time  
  -Gradient  
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  -Flow rate  
  -Temperature  
  -Separation purpose  
3.2.1.6 Column outputs - (a) detection  
  - Equipment used for detection  
    - Type   
  - Equipment settings  
  - Timescale over which data was collected  
  - Trace  
3.2.1.7 Column outputs - (b) fractions (if required)  
   - Fraction name 
   - Fraction description  
3.2.2 Liquid digestion of fractions, if required  
  - Digestion buffer  
  - Enzyme  
  - Incubation parameters 
  - Previous treatment  
3.2.3 Other parameters  
 
 
4. Peptide Purification/Fractionation   
 
4.1  HPLC  
 - Origin of the sample 
4.1.1 Equipment   
4.1.1.1 Product details for column   
  - Make  
  - Model  
  - Separation mode  
4.1.1.2 Physical characteristics of column  
  - Length  
  - Diameter  
  - Description of stationary phase  
4.1.1.3 Chromatography system used for separation  
4.1.2 Mobile phase: for each mobile phase  
   - Name of mobile phase 
   - Description of the constituents  
4.1.3 Properties of the column run  
  - Time  
  - Gradient  
  - Flow rate  
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
09
.3
13
1.
1 
: P
os
te
d 
22
 A
pr
 2
00
9
LP-CSIC/UAB                                                                                                                        Sample Preparation for Phosphoproteomics v 0.91  
 6 
  - Temperature  
  - Separation purpose  
4.1.4a Column outputs - (a) detection  
  - Equipment used for detection  
  - Type  
  - Equipment settings  
  - Timescale over which data was collected  
  - Trace  
4.1.4b Column outputs - (b) fractions (if required)  
  - Fraction name 
  - Fraction description  
4.1.5 Other parameters 
 
 
5. Phosphopeptide Enrichment (Repeat the steps as necessary) 
 
5.1 Method 1   
  - Method description  
5.1.1 Starting sample  
  - Origin of the sample  
  - Volume  
  - Pretreatment  
  - Loading buffer 
5.1.2 Affinity material  
  - Description of the affinity material  
  - Pretreatment of the affinity material  
5.1.3 Affinity purification procedure  
  - Volume of sample  
  - Amount of affinity material  
  - Type of purification  
  - Incubation time   
  - Incubation temperature  
  - Washing buffer  
   - Elution buffer  
   - Name of the obtained fractions  
5.1.4 Other parameters  
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Appendix I. The MIAPE Sample Preparation for Phosphoproteomics glossary of required-terms 
 Classification Definition 
1. General features 
1.1 Date stamp (as yyyy-mm-dd) 
The date on which the work described was initiated; 
given in the standard yyyy-mm-dd format (with 
hyphens) 
1.2 Responsible person or institutional 
role 
The (stable) primary contact person for this data set: 
this could be the experimenter, lab head, line manager, 
etc. Where responsibility rest with an institutional role 
(e.g. One of a number of duty officers) rather than a 
person, give the official name of the role rather than 
any one person. In all cases give affiliation and stable 
contact information, which consists of (i) Name, (ii) 
Postal address and (iii) Email address. 
1.3 Sample/s name/s 
Name of the samples processed. Include if there are 
control, standard of test samples and if samples are a 
pool of different individual. 
1.4 Replicates Number of replicates of the experiment. 
2. Sample Processing 
2.1 Culture/tissue handling 
  
 Tissue/Cell/Fluid type Biological material used in the experiment.  
 
Source Source from which the material is obtained (e.g. T-cells from buffy coat) 
 
Species Species of procedence 
 Isolation/Collection Method Surgical procedure, laser capture, intravenous blood 
extraction, etc 
2.1.1 Cells 
 
2.1.1.1 Cell Isolation Method 
Method used for cell isolation (e.g. Ficoll-Paque T-cells 
purification from buffy coat, enzymatic digestion, 
explant culture...) 
2.1.1.2 Culture parameters 
  
 
Culture medium Growth medium with all the complements added 
 
Culture conditions Temperature and gas mixture (typically for mammalian 
cells, 37ºC, 5% CO2) 
 
Cell density Number of cells per mL 
 
Type of culture Indicate if there are suspension or adherent cells and if they are primary cultures 
 
Time of culture Time which the cells are in culture and number of previous passages. 
2.1.1.3 Cell treatment 
  
 
Starting Amount Number of cells submitted to treatment 
 
Culture medium Culture medium for activation with all the complements 
added 
 
Culture conditions Temperature and gas mixture used for treatment 
 
Cell Treatment Cell treatment (activator,drug). Include concentration 
and buffers used for addition 
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Cell density Number of cells per mL during treatment 
 
Time Time for which the cells are treated. 
2.1.1.4 Pellet preparation Procedure used to prepare the pellet (wash, 
centrifugation or other parameters) 
2.1.1.5 Cell/Pellet lysis 
  
 
Starting amount Number of cells submitted to lysis.   
 
Lysis buffer Buffer used for cell lysis (Indicate all the components,   
concentration and pH). 
 
Phosphatase inhibitors used Name, manufacturer, reference, composition and 
amount added to the buffer. 
 
Other enzyme inhibitors Name, manufacturer, reference, composition and 
amount added to the buffer. 
 
Volume Volume of buffer used for lysis (in SI units). 
 
Homogenization or sonication 
methods 
Method used for cell/tissue disruption, include the time 
and power of the homogenization or sonication 
process. 
 
Centrifugation Centrifugation time and centrifugal force to obtain a 
clarified protein solution 
2.1.1.6 Other procedures 
Other procedures or treatments performed in cell  
preparation not included in 2.1.1.1.to 2.1.1.5 
2.1.2 Solid Tissues 
 
2.1.2.1 Tissue disruption 
 
 
Starting Amount Mass in SI units of starting material. Indicate whether it is wet or dry weight   
 
Lysis buffer Buffer used for tissue disruption (Indicate all the 
components,  concentration and pH). 
 
Phosphatase inhibitors used Name, manufacturer, reference, composition and 
amount added to the buffer 
 
Other enzyme inhibitors Name, manufacturer, reference, composition and 
amount added to the buffer. 
 
Volume Volume of buffer used for lysis (in SI units). 
 
Homogenization or sonication 
methods 
Method used for tissue disruption. Include the time and 
power of the homogenization or sonication process. 
 
Centrifugation Centrifugation time and centrifugal force 
2.1.2.2 Other procedures 
Other procedures or treatments performed in tissue 
preparation not included in 2.1.2.1. 
2.1.3 Fluids 
 
 Starting Volume Volume of initial fluid used for the analysis (in SI units) 
 Buffer used for dilution 
Buffer used for fluid dilution prior to protein depletion, 
digestion or other procedure (Indicate all the 
components,  concentration and pH). . 
 Phosphatase inhibitors used Name, manufacturer, reference, composition and 
amount added to the sample. 
 
Other enzyme inhibitors Name, manufacturer, reference, composition and 
amount added to the buffer. 
 
Protein deplection method (if 
required) 
If required indicate the method of protein depletion, the 
manufacturer and any significative customization from 
the original procedure. 
2.2 Protein Precipitation 
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 Starting Volume Volume of sample used for protein precipitation (in SI 
units) 
 Reagents and conditions 
Reagents used for precipitation. Indicate the 
composition and the volume added to the sample (in SI 
units). 
 Centrifugation Centrifugation time and centrifugal force. 
 Redissolution 
Buffer used to dissolve the precipitated proteins. 
Indicate the composition and the volume added to the 
pellet (in SI units). Also indicate if additional procedures 
as sonication or incubation are used to increase protein 
solubilization. 
2.3 Protein Digestion  
  
 
Starting Amount Mass in SI units of starting material. 
2.3.1 Pretreatment 
  
 Reduction Reagents, time, temperature and concentration. 
 Alkykation Reagents, time, temperature and concentration 
 Others Other treatments before digestion. Include reagents, time, temperature and concentration. 
2.3.2 Digestion parameters 
  
 
Protein concentration Concentration of protein extract submitted to digestion. 
 
Digestion buffer Buffer used for digestion. Indicate components, 
concentration and pH 
 
Enzyme Enzyme description (solubilization buffer and 
concentration). 
 
Incubation parameters Incubation time and temperature 
2.4 Peptide/Protein Labeling 
  
 
Type of labeling Type and make of the labeling reactive (e.g. iTRAQ from Applied Biosystems) 
 
Significative customizations Any significant deviations from the manufacture's protocol 
2.5 Other treatments Other procedures or treatments performed in the 
sample preparation not included in 2.1.to 2.4 
3. Protein Purification/Fractionation 
3.1 1D SDS-PAGE and in-gel digestion (From HUPO-PSI MIAPE:Gel Electrophoresis vs 1.4, January 2008) 
 
Starting Material Mass in SI units (cells or tissues) or volume of fluid 
submitted for separation. 
3.1.1 Gel matrix and electrophoresis 
  
 
Description of gel matrix 
Gel matrix being used. Include the descriptive name of 
the matrix (e.g. IPG strip, slab gel) and the type of the 
matrix used (e.g. a native gel, denaturing gel, gradient 
gel, etc.). State whether the matrix is composed of 
more than one kind of gel and name the parts (e.g. 
stacking gel). Give the dimensions of the matrix and 
associated parts, under the physical dimension section, 
below. 
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Gel manufacturer 
If the gel was purchased pre-cast, then include the 
model name, model number, batch number and 
manufacturer. If the gel has been manufactured ’in 
house’ then a reference to published protocol should 
be given. If no published protocol is available a recipe 
should be given. 
 
Physical dimensions 
The physical dimensions of the gel matrix. The 
measurements must be in the form of the Cartesian 
Coordinate system (x,y,z). According to the standard 
image orientation described in section 7.1.6, x 
represents the distance from the anode (+) to the 
cathode (−). (For example in an IPG strip x = the strip 
length, for a standard slab gel, x = the width). z = the 
matrix depth. 
 
Physicochemical property range and 
distribution 
As applicable, the details of the pH distribution of the 
matrix, including the overall pH range of the gel, if 
known. Details of the molecular weight distribution of 
matrix with appropriate measurement unit. Examples 
include linear pH 4-7, logarithmic apparent molecular 
mass 200-10 kDa. 
 
Acrylamide concentration 
The acrylamide concentration of the gel, or each 
matrix. In the form of a single percentage (1%) or 
gradient (1-2%). For gradients include the gradient 
distribution if appropriate, (e.g. fixed, stepped or liner).  
 
Acrylamide:crosslinker ratio 
The acrylamide to bisacrylamide ratio of the gel (Name 
of crosslinker and ratio described as 
"acrylamide:crosslinker") 
 
Gel lane The number of lanes on the gel matrix 
 
Sample application 
Description of the sample as applied to the matrix, 
giving: 1. Name of sample, Volume of loading buffer, 
Sample loaded per lane (if applicable for quantification, 
in SI measurement), and lane designation 
 
Buffer Description of the running buffers used, in terms of 
name of buffer, components with concentrations.  
 
Equipment Apparatus used for electrophoresis. Include brand and 
model. 
 
Electrophoresis conditions 
The running conditions applied to the gel (To be given 
in terms of voltages versus time/kilovolt hours, (or 
appropriate measurements) and temperature).  
3.1.2 Staining Staining method used to develop the gel image. 
3.1.3 In gel digestion 
  
 
Digestion buffer Buffer used for digestion, indicating components, 
concentration and pH 
 
Enzyme Enzyme description (solubilization buffer and 
concentration). 
 
Incubation parameters Incubation time and temperature 
 
Previous treatment Previous treatment if required (e.g. Reduction and/or 
alkylation) 
 
Automatic digestor If required, brand and model of the apparatus used 
3.2 HPLC and liquid digestion (From HUPO-PSI MIAPE::Column Chromatography vs 1.0, June 2008) 
 
Starting Material Mass in SI units (cells or tissues) or volume of fluid 
submitted for separation. 
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3.2.1 Equipment 
  
3.2.1.1 Product details for column 
  
 
Make The name of the manufacturer 
 
Model The model number provided by the manufacturer 
 
Separation mode 
A description of the type of column being used (e.g., 
Separation mechanism: affinity, anion exchange, cation 
exchange, reverse phase, size). 
3.2.1.2 Physical characteristics of column 
  
 
Length The length of the column. 
 
Diameter The internal diameter of the column. 
 
Description of stationary phase 
A description of the constituents of the stationary 
phase, including the name of the packing material and 
the particle size. 
3.2.1.3 
  
Chromatography system used for 
separation, where applicable 
The name of the manufacturer and the model name 
provided by the manufacturer. 
3.2.1.4 Mobile phase: for each mobile phase 
  
 
Name of mobile phase Name used to refer to mobile phase in Properties of Column run 
 
Description of the constituents For each constituent, a description and the 
concentration 
3.2.1.5 Properties of the column run 
  
 
Time The length of time for which the column is run. The 
value can be provided as a duration of time,  
 
Gradient 
The proportion of each of the mobile phases at a point 
in time, or the function describing the gradient, 
including the overall duration of the gradient. There 
may be several steps that together make up the 
gradient. 
 
Flow rate 
The rate at which the mobile phase is applied to the 
column, including the time period for which this holds if 
it varies during the experiment. 
 
Temperature 
The temperature at which the column is run, including 
the period for which this holds if it varies during the 
experiment 
 
Separation purpose Analytical or preparative 
3.2.1.6 Column outputs - (a) detection 
  
 
Equipment used for detection Make, model and description 
 
Type 
A description of the kind of detector (e.g. UV) and a 
description of control properties of the detector, such 
as the wavelength that is being detected 
 
Equipment settings A description of control properties of the detector, such 
as the wavelength that is being detected 
 
Timescale over which data was 
collected 
The time range covered by the trace produced by the 
detector 
 
Trace The location and format of the trace 
3.2.1.7 Column outputs - (b) fractions (if 
required) 
  
 
Fraction name An optional name, unique within a run, by which a fraction can be referenced. 
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Fraction description 
Either a description of the procedure by which the 
fractions were collected (i.e. start/end time, size (time 
or volume), mode (fixed or peak directed), or a 
description of the individual fractions (e.g. time of 
collection, volume) 
3.2.2 Liquid digestion of fractions, if 
required 
 
 
Digestion buffer Buffer used for digestion, indicating components, 
concentration and pH 
 
Enzyme Enzyme description and concentration 
 
Incubation parameters Incubation time and temperature 
 
Previous treatment Previous treatment if requires (e.g. Reduction and/or 
alkylation) 
3.2.3 Other parameters Other parameters performed not included in 3.2.1 to 3.2.2 
4. Peptide Purification/Fractionation 
4.1 HPLC (From HUPO-PSI MIAPE::Column Chromatography vs 1.0, June 2008) 
 
Origin of the sample 
The origin of the peptide mixture submitted to 
purification: solution from in-gel digestion, liquid 
digestion, etc 
4.1.1 Equipment 
  
4.1.1.1 Product details for column 
  
 
Make The name of the manufacturer 
 
Model The model number provided by the manufacturer 
 
Separation mode 
A description of the type of column being used (e.g., 
Separation mechanism: affinity, anion exchange, cation 
exchange, reverse phase, size). 
4.1.1.2 Physical characteristics of column 
  
 
Length The length of the column. 
 
Diameter The internal diameter of the column. 
 
Description of stationary phase 
A description of the constituents of the stationary 
phase, including the name of the packing material and 
the particle size. 
4.1.1.3 Chromatography system used for 
separation 
The name of the manufacturer and the model name 
provided by the manufacturer. 
4.1.2 Mobile phase: for each mobile phase 
  
 
Name of mobile phase Name used to refer to mobile phase in Properties of Column run 
 
Description of the constituents For each constituent, a description and the 
concentration 
4.1.3 Properties of the column run 
  
 
Time The length of time for which the column is run. The 
value can be provided as a duration of time,  
 
Gradient 
The proportion of each of the mobile phases at a point 
in time, or the function describing the gradient, 
including the overall duration of the gradient. There 
may be several steps that together make up the 
gradient. 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
09
.3
13
1.
1 
: P
os
te
d 
22
 A
pr
 2
00
9
LP-CSIC/UAB                                                                                                                        Sample Preparation for Phosphoproteomics v 0.91  
 13 
 
Flow rate 
The rate at which the mobile phase is applied to the 
column, including the time period for which this holds if 
it varies during the experiment. 
 
Temperature 
The temperature at which the column is run, including 
the period for which this holds if it varies during the 
experiment 
 
Separation purpose Analytical or preparative 
4.1.4a Column outputs - (a) detection 
  
 
Equipment used for detection Make, model and description 
 
Type 
A description of the kind of detector (e.g. UV) and a 
description of control properties of the detector, such 
as the wavelength that is being detected 
 
Equipment settings A description of control properties of the detector, such 
as the wavelength that is being detected 
 
Timescale over which data was 
collected 
The time range covered by the trace produced by the 
detector 
 
Trace The location and format of the trace 
4.1.4b Column outputs - (b) fractions (if 
required) 
  
 
Fraction name An optional name, unique within a run, by which a fraction can be referenced. 
 
Fraction description 
Either a description of the procedure by which the 
fractions were collected (i.e. start/end time, size (time 
or volume), mode (fixed or peak directed), or a 
description of the individual fractions (e.g. time of 
collection, volume) 
4.1.5 Other parameters Other parameters not included in 4.1.1. 
5. Phosphopeptide Enrichment  (Repeat the steps as necessary) 
5.1 Method 1 
  
 Method description Brief description of the method (e.g. IMAC purification) 
5.1.1 Starting sample 
 
 Origin of the sample 
The origin of the peptide mixture submitted to 
purification: solution from in-gel digestion, eluate from 
HPLC or other peptide enrichment procedure, etc 
 Volume Initial volume of the peptide mixture to be purified 
 Pretreatment Volume reduction, sample dilution, dessalting, etc... 
 Loading buffer Buffer (type and volume) used to dissolve or dilute the 
sample and to load it into the resin 
5.1.2 Affinity material 
 
 Description of the affinity material 
Material used for phosphopeptide enrichment. Include 
name of the manufacturer, reference and, if required, 
type of metal loaded in the material . 
 Pretreatment of the affinity material Procedures used to suspend, wash and conditionate the affinity material (buffers, time and volume). 
5.1.3 Affinity purification procedure 
 
 Volume of sample Volume of sample used for purification (in SI units). 
 Amount of affinity material Amount of affinity material used for purification (in SI 
units). 
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 Type of purification 
In-batch or in-column purification (indicate the type of 
tube, holder or other container used for the 
purification). 
 Incubation time Incubation time of the sample with the resin 
 Incubation temperature Incubation temperature of the sample with the resin 
 Washing buffer Buffer (type and volume) used to wash the affinity 
material after incubation. 
 Elution buffer Buffer (type and volume) used to elute the phosphopeptides from the resin. 
 Name of the obtained fractions 
Code identifying the eluted extract and/or. if appropiate, 
the unretained fraction to be submitted to other 
analyses. 
5.1.4 Other parameters Other parameters not included in 5.1.1 to 5.1.3. 
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